Introduction to Mounjaro The recent arrival of Mounjaro, a novel medication for type 2 diabetes, is garnering significant attention in the medical community. Developed by Eli Lilly, Mounjaro (tirzepatide) represents a new class of treatment that mimics the effects of two hormones involved in the regulation of glucose and appetite: GIP (Gastric Inhibitory Polypeptide) and
Introduction to Mounjaro The recent arrival of Mounjaro, a novel medication for type 2 diabetes, is garnering significant attention in the medical community. Developed by Eli Lilly, Mounjaro (tirzepatide) represents a new class of treatment that mimics the effects of two hormones involved in the regulation of glucose and appetite: GIP (Gastric Inhibitory Polypeptide) and